NL-OMON51139招募中4 期
Efficacy of vaccine responses against SARS-Cov-2 in patients with giant cell arteritis and polymyalgia rheumatica (GPSVAC) - GPSVAC
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •Give written informed consent
- •Diagnosed with GCA or PMR
排除标准
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •Concomitant chronic diseases that may affect the immune system (such as prior
- •or current malignant disease, active infectious disease, other rheumatic
- •disease, kidney disease, active allergy etc.)
- •Severe anaemia defined as a hemoglobin of less than 6,0 g/dL
- •Confirmed SARS-CoV-2 infection (current or previous)
研究者
相似试验
已完成
不适用
Immune response against SARS-CoV-2 vaccinatioCOVID-19DRKS00028174DKFZ6
尚未招募
不适用
Response rate to SARS-CoV-2 (COVID-19) vaccine in dialysis patients.JPRN-UMIN000043368agasaki University110
暂停
不适用
Analysis of the effect of SARS-CoV-2 vaccination in patients with chronic inflammatory diseasesDRKS00024214KSH Kiel/1. medizinische Klinik/Rheumatologie100
进行中（未招募）
1 期
SARS-CoV-2 immune responseimmune response to COVDI-19 vaccinationEUCTR2021-001202-30-NLDiakonessenhuis400
已完成
4 期
ong term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease stage G4-G5, on dialysis or after kidney transplantation. A prospective observational cohort study by the REnal patients COVID-19 VACcination (RECOVAC) consortiumniertransplantatie, nieraandoeningen zowel in- als exclusief nefropathieëndialysiskidney insufficiencykidney transplantatie1004743810038430NL-OMON50845niversitair Medisch Centrum Groningen12,000